Collaboration to offer heart rhythm checks to detect atrial fibrillation
March 22, 2022Manufacturing and Production
Daiichi Sankyo and O’Brien’s Pharmacies Group have today announced the launch of a collaboration in North West England to offer …
Ipsen appoints Guy Oliver as General Manager, UK & Ireland
March 21, 2022Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
FDA approval for first in class immunotherapy for advanced melanoma
March 21, 2022Sales and Marketing
The FDA has approved Bristol-Myers Squibb’s Opdualag (nivolumab and relatlimab-rmbw), the first drug in a new class of cancer immunotherapies, …
Spring COVID-19 booster launches for over-75s and high risk in England
March 21, 2022Sales and Marketing
Those aged 75 and over, alongside residents in care homes and those with weakened immune systems, can now book an …
UCLA’s HIV prevention and treatment centre receives $7.5 million NIH grant
March 21, 2022Sales and Marketing
The National Institute of Mental Health has renewed its support for UCLA’s collaborative Centre for HIV Identification, Prevention and Treatment …
Merck’s Keytruda delivers reduced risk of death in adjuvant NSCLC
March 21, 2022Sales and Marketing
Merck has announced positive results from its Phase III trial into Keytruda for non-small cell lung cancer. The KEYNOTE-091 study …
Moderna seeks FDA authorisation for fourth COVID-19 jab for adults
March 18, 2022Medical Communications
Moderna has requested an EUA from the FDA for a fourth dose of its COVID-19 vaccine, as a booster for …
NIH fund research for Short Bowel Syndrome
March 18, 2022Medical Communications
A Saint Louis University School of Medicine physician-scientist has received funding of $428,020, from the National Institutes of Allergy and …
GSK halts new clinical trials in Russia
March 18, 2022Medical Communications
Britain’s second biggest drugmaker, GlaxoSmithKline (GSK), has joined other pharmaceutical companies including Pfizer, sharing that it will not start clinical …
AstraZeneca could abandon US regulatory efforts for COVID-19 vaccine
March 18, 2022Medical Communications
The Oxford/AstraZeneca vaccine has not yet been approved in the US, and has not been submitted for Emergency Use Authorisation …
Global COVID-19 cases up for first time in weeks
March 17, 2022Business Services
After more than a month of decline, global cases of COVID-19 have increased. WHO have stated that cases of the …
War in Ukraine could worsen COVID-19 pandemic, says WHO
March 17, 2022Business Services
WHO has expressed concern that the war in Ukraine could worsen the COVID-19 pandemic, and it is aiming to do …
Ukraine: Health facilities a “target” of war
March 17, 2022Business Services
Healthcare facilities have become a “target” of war, WHO has said, warning that the health system in Ukraine is “teetering …
Targeted drug Olaparib improves survival in early-stage breast cancer
March 17, 2022Business Services
The Institute of Cancer Research (ICR), London, has reported new findings that the targeted drug olaparib improves survival in women …
Shaping the new frontiers of women’s health
March 16, 2022March 8 was International Women’s Day and provided a perfect opportunity for Pharmafocus to dive deep into women’s health. Lina …
Sanofi and Seagen collaborate to develop novel antibody-drug conjugates
March 16, 2022Research and Development
Sanofi and Seagen announced an exclusive collaboration agreement to design, develop, and commercialise antibody-drug conjugates (ADCs) for up to three …
NICE guidance for treating relapsed and refractory multiple myeloma
March 16, 2022Research and Development
NICE has published guidance from the new cancer drug, daratumumab, for the treatment of relapsed and refractory myeloma. Around 350 …
FDA approves Symbicort to treat asthma and COPD
March 16, 2022Research and Development
The FDA has approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, for the treatment of …
FDA clearance for clinical surveillance solution
March 16, 2022Research and Development
The latest Philips Capsule Surveillance solution has received market clearance from the FDA, paving the way for widespread deployment across …
Sanofi and Blackstone Life Science collaborate to advance multiple myeloma treatment
March 15, 2022Manufacturing and Production
Sanofi and Blackstone announced a strategic, risk-sharing €300 million collaboration, to advance innovative treatment for multiple myeloma. This funding will …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
